Judith Álvarez Otero

Judith Álvarez Otero

Auto-generated profile, based on publicly available information

Judith Álvarez Otero

Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2024 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
JOJudith Alvarez Otero
Judith Alvarez Otero
JMJay Mandrekar
Jay Mandrekar
MWMatt J. Wolf
Matt J. Wolf
JSJordan C. Starkey
Jordan C. Starkey
ECEva M. Carmona
Eva M. Carmona
RPRobin Patel
Robin Patel
The definition of the microbiology of pleural space infection has been challenging due to the poor yield of conventional culture. Here, the results of a 16S ribosomal RNA gene PCR/sequencing assay performed on pleural fluid in routine clinical practice between August 2020 and January 2023 were evaluated. Amplified 16S rRNA gene DNA was submitted to Sanger sequencing and/or next-generation sequencing or results were reported as negative, depending on PCR crossing threshold value. In all, 496 pleural fluids were tested at Mayo Clinic Laboratories, with 227 positive results, including 57 from Mayo Clinic patients. Among the 57 Mayo Clinic patients, pleural space infection was community acquired in 48 (84%); Fusobacterium nucleatum group and/or Streptococcus intermedius were detected in 31/57 (54%) cases [including 28/48 (58%) community-acquired cases], with additional facultative and/or anaerobic species also found in various combinations in 17/31 (55%). Results of this study suggest that the most frequent microorganism profile involved in community-acquired pleural space infection may be a combination of F. nucleatum group and/or S. intermedius , with or without other normal microbiota. IMPORTANCE: We describe here the most frequent microorganisms detected in community-acquired pleural space infection using a clinically performed sequencing-based assay. We found that the most common detection was the Fusobacterium nucleatum group and/or Streptococcus intermedius , with or without other normal microbiota. We propose the term e-FuSion (effusion with Fusobacterium nucleatum group, Streptococcus intermedius , and other oral normal microbiota) for this entity.

15 September 2020 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
JOJudith Álvarez Otero
Judith Álvarez Otero
JFJose Luis Lamas Ferreiro
Jose Luis Lamas Ferreiro
ARAna Sanjurjo Rivo
Ana Sanjurjo Rivo
JAJavier de la Fuente Aguado
Javier de la Fuente Aguado
We present a case of Pseudomonas aeruginosa osteomyelitis treated with surgery and antibiotic therapy with ceftolozane-tazobactam in continuous infusion at home using an elastomeric pump. We discuss the use of ceftolozane-tazobactam in continuous infusion administered at home as an effective alternative for the treatment of multidrug-resistant Pseudomonas aeruginosa osteomyelitis.

19 October 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JOJudith Álvarez Otero
Judith Álvarez Otero
JFJose Luis Lamas Ferreiro
Jose Luis Lamas Ferreiro
ARAna Sanjurjo Rivo
Ana Sanjurjo Rivo
FPFernando Maroto Piñeiro
Fernando Maroto Piñeiro
LGLucía González González
Lucía González González
JAJavier De La Fuente Aguado
Javier De La Fuente Aguado
Urinary tract infections caused by extended-spectrum beta-lactamase producing Enterobacterales (ESBL-EB) are a problem increasing in our clinical practice. The aim of this study was to evaluate the clinical outcome in patients who received short (≤ 7 days) versus long courses (>7 days) of antimicrobial therapy for complicated ESBL-EB urinary tract infections. This is a retrospective and observational study. Positive urine cultures for ESBL-EB in our hospital between March 2015 and July 2017 were identified. Patients with complicated urinary tract infection were included. Differences between treatment groups (7 days or less vs more than 7 days) were analyzed according to baseline characteristics and severity of clinical presentation. Primary outcome was all cause 30-day mortality. Secondary outcome was a combined item of all cause mortality and reinfection by the same enterobacteria at 30 days. 273 urine cultures were positive for ESBL-EB during the study period. 75 episodes were included, 40 in the long treatment group and 35 in the short treatment group. Mean treatment duration in short and long treatment groups was 6,1 and 13,8 days respectively. Mortality at 30 days was 5,7% in the short treatment group and 5% in the long treatment group without significant differences (P = 0,8). Mortality or reinfection by the same ESBL-EB at 30 days was 8,6% in the short treatment group and 10% in the long treatment group, without significant differences (P = 0,8). Short courses of antimicrobial treatment seems to be effective as treatment of complicated urinary tract infections by ESBL-EB.

1 October 2015 in Revista Clínica Española
Verified
Journal Article
Closed access
JÁJ. Álvarez-Otero
J. Álvarez-Otero
JFJ. de la Fuente-Aguado
J. de la Fuente-Aguado
JAJ.C. Arias-Castaño
J.C. Arias-Castaño
LGL. González-González
L. González-González
RPR. Puerta-Louro
R. Puerta-Louro
SAS. Araújo-Fernández
S. Araújo-Fernández

1 January 2016 in Revista Española de Enfermedades Digestivas
Verified
Journal Article
Open access
JOJudith Álvarez Otero
Judith Álvarez Otero
FFFrancisco Fernández Fernández
Francisco Fernández Fernández
JAJavier De La Fuente Aguado
Javier De La Fuente Aguado
Alopecia areata produces hair loss in circular patches by an immune mechanism. The association with hematologic malignancies and with digestive tumors has been described. We report the case of a man who presented alopecia areata and two months later he was diagnosed with gastric adenocarcinoma.

1 January 2016 in Enfermedades Infecciosas y Microbiología Clínica
Verified
Journal Article
Closed access
JOJudith Álvarez Otero
Judith Álvarez Otero
FFFrancisco Fernández Fernández
Francisco Fernández Fernández
MVMaría González Vázquez
María González Vázquez
JAJavier de la Fuente Aguado
Javier de la Fuente Aguado